Looking for excipients offered by BASF? Find information on BASF's regulatory filings (DMFs), cGMP inspections, pricing availability, etc. on PharmaCompass.

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We create chemistry for a sustainable future. In line with our corporate purpose, around 112,000 employees contribute to the success of our customers in nearly all sectors and almost every country in the world. Our broad portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. In 2015, BASF posted sales of €70 billion and income from operations before special items of app...
We create chemistry for a sustainable future. In line with our corporate purpose, around 112,000 employees contribute to the success of our customers in nearly all sectors and almost every country in the world. Our broad portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. In 2015, BASF posted sales of €70 billion and income from operations before special items of approximately €6.7 billion. We combine economic success with environmental protection and social responsibility. Through research and innovation, we support our customers in nearly every industry.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Carl-Bosch-Strasse 38 Ludwigshafen , Rhineland-Palatinate 67056
Telephone
Telephone
+49-(0)-621-600
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

CPhI South East Asia

Not Confirmed

envelop Contact Supplier

CPhI South East Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets
With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

Impressions: 1293

https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

Radio Compass
06 May 2025

VLOG #PharmaReel

[Sponsored by another company]
This PharmaReel highlights Gentec Pharmaceutical's expertise in generic APIs, HPAPIs, and prostaglandins with more than 30 years of experience. Operating from EU-GMP-certified facilities, the company exports to over 70 countries worldwide.

Impressions: 99

read-more

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint
During the second quarter (Q2) of 2025, contract development and manufacturing organizations (CDMOs) made substantial investments in specialized therapeutic manufacturing. The quarter also saw CDMOs pursue high-value, complex manufacturing niches, particularly in antibody-drug conjugates (ADCs), cell and gene therapies (CGTs) and oligonucleotides.Alongside these trends, Q2 also saw CDMOs strengthen their footprint in the United States amid concerns over rising tariffs and unpredictable trade policies being enforced by the Trump administration.Regeneron Pharmaceuticals committed over US$ 3 billion through a 10-year agreement with Fujifilm Diosynth Biotechnologies to nearly double its US manufacturing capacity for biologics. Under this agreement, Fujifilm will manufacture and supply drug products for Regeneron at its large-scale facility in Holly Springs, North Carolina.Thermo Fisher Scientific announced plans to invest an additional US$ 2 billion in the US over four years, reinforcing its manufacturing and R&D capabilities. With 64 facilities spread across 37 states, Thermo Fisher aims to bolster American innovation and competitiveness. Similarly, Piramal Pharma announced a US$ 90 million investment plan for expanding two facilities in the US, thereby bringing its total investment in the country to US$ 570 million. View CDMO Activity Tracker for Q2 2025 (Free Excel Available)Veranova, Carbogen lead ADC wave; Axplora doubles down on HPAPI production in ItalyThe quarter saw substantial investments in ADC manufacturing. Veranova announced a US$ 20 million investment in bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus. With this investment, Veranova will be able to provide a more comprehensive suite of services to its partners developing ADCs and other bioconjugates. Veranova’s total investment in the Devens facility now stands at over US$ 50 million. Swiss CDMO Carbogen announced a US$ 31 million co-investment with an unnamed Japanese investor to expand its capabilities across its Aarau and Neuland (Switzerland) facilities. The facility will address increasing demand for complex and high-value compounds such as ADC drug linkers.Axplora announced a further €35 million (US$ 41 million) expansion of its Farmabios site in Italy, doubling the facility to approximately 108,000 square meters by mid-2026. This investment raises its total spend on the site to over €80 million (US$ 94.05 million) since 2019, supporting the production of highly potent active pharmaceutical ingredients (HPAPIs). Farmabios now stands as a key hub in Axplora’s global CDMO network.Polish pharmaceutical manufacturer Polfa Tarchomin is positioning itself as a significant player in the European CDMO market through its investment in the Center for Development and Production of Highly Potent Drugs. This 12,000 square meter facility has two state-of-the-art production lines designed for filling vials and pre-filled syringes with an annual capacity of 26 million product units.Skyepharma’s projected annual revenues from oncology-linked activities touched €10 million (US$ 11.2 million). The CDMO’s facility in Saint-Quentin-Fallavier is equipped to handle cytotoxic and cytostatic compounds, and is one of the few facilities in France capable of managing HPAPIs for oral anticancer treatments. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Athena acquires Medipha Santé, Famar buys MiP Pharma’s German site to strengthen European footprintDuring the quarter, several CDMOs enhanced their strategic capabilities through M&As. Athena Pharmaceutiques acquired  Medipha Santé to build a fully integrated pharmaceutical services platform in Europe. Based in Paris, Athena has strengthened its commercial and regulatory toolbox by bringing aboard Medipha Santé’s 35-strong team, which supports over 100 partner organizations and files approximately 350 dossiers annually with ANSM and other European agencies. With this integration, Athena positions itself as a one-stop CDMO partner.With the acquisition of MiP Pharma’s sterile manufacturing site in Homburg, Germany, the Famar Group has expanded its capabilities in aseptic and lyophilized fill-and-finish operations. The acquisition has strengthened Famar’s position in sterile drug manufacturing. The CDMO now has seven manufacturing facilities in Europe.PCI Pharma Services’ acquisition of Ajinomoto Althea has established a world-class, large-scale manufacturing hub in the San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high-potent formulations such as ADCs. PCI Pharma is now amongst the few US-based CDMOs capable of comprehensive ADC manufacturing.Samsung Biologics’ strategic spinoff of its biosimilar business stood out as a significant corporate restructuring exercise during the quarter. The separation of Samsung Bioepis, tentatively renamed Samsung Epis Holdings, aims to enhance Samsung Biologics’ strategic focus and build client trust, as it eliminates potential conflicts between CDMO services and proprietary drug development. The move came after Samsung Biologics inked a contract worth 737.3 billion Korean won (US$ 518 million) with an undisclosed US pharmaceutical company.WuXi Biologics announced a US$ 167 million divestment of its German facility to Terumo and broke ground on a microbial production plant in China. National Resilience, which was launched five years ago as the US drug manufacturer dedicated to broadening access to medicines and protecting biopharma supply chains, said it is shuttering six of its 10 facilities. The company said the sites were “not being fully utilized.” View CDMO Activity Tracker for Q2 2025 (Free Excel Available) MilliporeSigma, Simtra form 5-year ADC alliance; Silexion partners Catalent for siRNA developmentMerck KGaA’s MilliporeSigma and Simtra struck a five-year strategic alliance, combining expertise across the ADC value chain to reduce development timelines and complexity for biopharmaceutical companies. Viralgen collaborated with Trogenix to rapidly scale product supply for TGX-007, an AAV gene therapy for glioblastoma (a type of cancer of the brain and spinal cord).  Silexion announced a collaboration with Catalent for small interfacing RNA (siRNA) development and manufacturing. Catalent’s Limoges (France) facility will conduct formulation development and clinical manufacturing for Silexion’s SIL204 candidate, supporting both systemic and intra-tumoral delivery formulations.Skyepharma’s collaboration with Eneapharm through the Skyehub platform aims to support the treatment of patients suffering from exocrine pancreatic insufficiency, including those affected by cystic fibrosis or pancreatic cancer. Orion Corporation reached an agreement with Shilpa Biocare for the distribution of recombinant human albumin in Europe.Meanwhile, Aenova announced the launch of its Aenovation program, an initiative designed to fast-track early development of pharmaceutical formulations. The program addresses the critical challenges of bioavailability and time-to-market faced by poorly soluble drug candidates. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Our view The quarter saw CDMO developments mimic the broader trends in the pharmaceutical industry, such as onshoring of critical manufacturing capabilities in the US, consolidation of specialized expertise through strategic partnerships, and the relentless focus on emerging therapeutic modalities that promise to transform patient care. With CDMOs continuing to invest in next-generation manufacturing capabilities, we expect the sector to play a crucial role in drug innovation. 

Impressions: 233

https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint

#PharmaFlow by PHARMACOMPASS
10 Jul 2025

NEWS #PharmaBuzz

read-more
read-more
BASF opens new GMP Solution Center in US
BASF opens new GMP Solution Center in US

23 Jun 2025

// INDPHARMAPOST

https://www.indianpharmapost.com/news/basf-opens-new-gmp-solution-center-in-us-17301

INDPHARMAPOST
23 Jun 2025

https://www.globenewswire.com/news-release/2025/02/10/3023415/0/en/KFSHRC-Detects-276-Fetal-Genetic-Disorders-Through-Prenatal-Care-Saving-SAR-360-Million-Annually.html

GLOBENEWSWIRE
10 Feb 2025

https://www.indianpharmapost.com/news/basf-sells-food-and-health-performance-ingredients-business-to-louis-dreyfus-company-16572

INDPHARMAPOST
24 Dec 2024

https://www.expresspharma.in/basf-introduces-pepsensyal-peptide-for-slow-aging-skin-care-solutions/

EXPRESSPHARMA
23 Oct 2024

https://www.reuters.com/markets/europe/basf-expected-announce-listing-plans-agri-chemicals-division-reports-bloomberg-2024-09-18/

REUTERS
18 Sep 2024

https://www.reuters.com/markets/commodities/german-chemical-sector-employers-union-agree-685-pay-hike-over-20-months-2024-06-27/

REUTERS
27 Jun 2024

01

Ibuprofen

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Ibuprofen

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

02

Omega-3-Acid Ethyl Esters 90

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Omega-3-Acid Ethyl Esters 90

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

03

Riboflavin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Riboflavin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF Inactive-api CEP/COS arrow-down JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

04

Vitamin E Acetate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Vitamin E Acetate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF Inactive-api CEP/COS arrow-down JDMF arrow-down EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

05

Icosapent Ethyl

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Icosapent Ethyl

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

06

Levomenthol

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Levomenthol

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

07

Omega-3-Acid Ethyl Esters 90

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Omega-3-Acid Ethyl Esters 90

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

08

Omega-3-Acid Ethyl Esters 90

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Omega-3-Acid Ethyl Esters 90

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Povidone Iodine

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Povidone Iodine

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

10

Riboflavin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Riboflavin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF Inactive-api CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-more

01

Acitretin

CEP/COS

EPS
Not Confirmed
arrow

04

Ascorbic acid

CEP/COS

EPS
Not Confirmed
arrow

05

Ascorbic acid

CEP/COS

EPS
Not Confirmed
arrow

06

EPS
Not Confirmed
arrow

08

Dexpanthenol

CEP/COS

EPS
Not Confirmed
arrow

09

Ibuprofen

CEP/COS

EPS
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Brand Name : IBU

EPS
Not Confirmed
arrow

Brand Name : IBU

arrow
EPS
Not Confirmed

BASF

Dosage Form : TABLET;ORAL

Brand Name : IBU

Dosage Strength : 400MG

Packaging :

Approval Date : 1982-01-01

Application Number : 18197

Regulatory Info : DISCN

Registration Country : USA

blank

02

Brand Name : IBU

EPS
Not Confirmed
arrow

Brand Name : IBU

arrow
EPS
Not Confirmed

BASF

Dosage Form : TABLET;ORAL

Brand Name : IBU

Dosage Strength : 400MG

Packaging :

Approval Date : 1985-02-22

Application Number : 70083

Regulatory Info : DISCN

Registration Country : USA

blank

03

Brand Name : IBU

EPS
Not Confirmed
arrow

Brand Name : IBU

arrow
EPS
Not Confirmed

BASF

Dosage Form : TABLET;ORAL

Brand Name : IBU

Dosage Strength : 600MG

Packaging :

Approval Date : 1985-03-29

Application Number : 70099

Regulatory Info : DISCN

Registration Country : USA

blank

04

Brand Name : RUFEN

EPS
Not Confirmed
arrow

Brand Name : RUFEN

arrow
EPS
Not Confirmed

BASF

Dosage Form : TABLET;ORAL

Brand Name : RUFEN

Dosage Strength : 600MG

Packaging :

Approval Date : 1984-03-05

Application Number : 18197

Regulatory Info : DISCN

Registration Country : USA

blank

05

Brand Name : IBU

EPS
Not Confirmed
arrow

Brand Name : IBU

arrow
EPS
Not Confirmed

BASF

Dosage Form : TABLET;ORAL

Brand Name : IBU

Dosage Strength : 600MG

Packaging :

Approval Date : 1985-02-08

Application Number : 70088

Regulatory Info : DISCN

Registration Country : USA

blank

06

Brand Name : IBU

EPS
Not Confirmed
arrow

Brand Name : IBU

arrow
EPS
Not Confirmed

BASF

Dosage Form : TABLET;ORAL

Brand Name : IBU

Dosage Strength : 800MG

Packaging :

Approval Date : 1986-07-23

Application Number : 70745

Regulatory Info : DISCN

Registration Country : USA

blank

07

Brand Name : Omacor

EPS
Not Confirmed
arrow

Brand Name : Omacor

arrow
EPS
Not Confirmed

BASF

Dosage Form : Kapsel, myk

Brand Name : Omacor

Dosage Strength : 1000 mg

Packaging : Boks av plast 98item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

Brand Name : IBU

EPS
Not Confirmed
arrow

Brand Name : IBU

EPS
Not Confirmed
arrow

BASF

Dosage Form : TABLET; ORAL

Proprietary Name : IBU

Dosage Strength : 400MG

Approval Date : 1982-01-01

Application Number : 18197

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

02

Brand Name : RUFEN

EPS
Not Confirmed
arrow

Brand Name : RUFEN

EPS
Not Confirmed
arrow

BASF

Dosage Form : TABLET; ORAL

Proprietary Name : RUFEN

Dosage Strength : 600MG

Approval Date : 1984-03-05

Application Number : 18197

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

03

Brand Name : IBU

EPS
Not Confirmed
arrow

Brand Name : IBU

EPS
Not Confirmed
arrow

BASF

Dosage Form : TABLET; ORAL

Proprietary Name : IBU

Dosage Strength : 400MG

Approval Date : 1985-02-22

Application Number : 70083

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

04

Brand Name : IBU

EPS
Not Confirmed
arrow

Brand Name : IBU

EPS
Not Confirmed
arrow

BASF

Dosage Form : TABLET; ORAL

Proprietary Name : IBU

Dosage Strength : 600MG

Approval Date : 1985-02-08

Application Number : 70088

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

05

Brand Name : IBU

EPS
Not Confirmed
arrow

Brand Name : IBU

EPS
Not Confirmed
arrow

BASF

Dosage Form : TABLET; ORAL

Proprietary Name : IBU

Dosage Strength : 600MG

Approval Date : 1985-03-29

Application Number : 70099

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

06

Brand Name : IBU

EPS
Not Confirmed
arrow

Brand Name : IBU

EPS
Not Confirmed
arrow

BASF

Dosage Form : TABLET; ORAL

Proprietary Name : IBU

Dosage Strength : 800MG

Approval Date : 1986-07-23

Application Number : 70745

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

Europe

read-more
read-more

01

Brand Name : Omacor

EPS
Not Confirmed
arrow

Brand Name : Omacor

arrow
EPS
Not Confirmed

BASF

Dosage Form : Kapsel, myk

Dosage Strength : 1000 mg

Packaging : Boks av plast 9...

Brand Name : Omacor

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Excipients

Click here to find the perfect excipient manufacturers by their capabilities

All Excipients

read-more
read-more

01

Crospovidone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Crospovidone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

02

Povidone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Povidone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

Povidone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Povidone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS Inactive-api JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Povidone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Povidone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF Inactive-api CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

Cocoyl Caprylocaprate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Cocoyl Caprylocaprate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Medium Chain Triglycerides Excipien...

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Medium Chain Triglycerides Excipien...

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Methacrylic Acid - Ethyl Acrylate C...

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Methacrylic Acid - Ethyl Acrylate C...

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Octyldodecanol

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Octyldodecanol

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Oleyl Alcohol

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Oleyl Alcohol

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Polyvinyl Acetate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Polyvinyl Acetate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

EPS
Not Confirmed
arrow

04

EPS
Not Confirmed
arrow

05

EPS
Not Confirmed
arrow

07

EPS
Not Confirmed
arrow

08

EPS
Not Confirmed
arrow

09

EPS
Not Confirmed
arrow

10

EPS
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Excipients by Ingredients

Upload your portfolio for free, ask us

Excipients By applications

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact BASF and get a quotation

BASF is a supplier offers 65 products (APIs, Excipients or Intermediates).

Find a price of Ibuprofen bulk with DMF, CEP, JDMF offered by BASF

Find a price of Omega-3-Acid Ethyl Esters 90 bulk with DMF, CEP, JDMF offered by BASF

Find a price of Riboflavin bulk with CEP, JDMF offered by BASF

Find a price of Vitamin E Acetate bulk with CEP, JDMF offered by BASF

Find a price of Icosapent Ethyl bulk with DMF, JDMF offered by BASF

Find a price of Levomenthol bulk with DMF, CEP offered by BASF

Find a price of Omega-3-Acid Ethyl Esters 90 bulk with DMF, CEP offered by BASF

Find a price of Povidone Iodine bulk with DMF, JDMF offered by BASF

Find a price of Riboflavin bulk with JDMF offered by BASF

Find a price of Vitamin A bulk with CEP offered by BASF

Find a price of Vitamin E bulk with CEP offered by BASF

Find a price of 2-Phenoxyethanol bulk with CEP offered by BASF

Find a price of Acitretin bulk offered by BASF

Find a price of Ascorbic Acid bulk offered by BASF

Find a price of Azelaic Acid bulk with DMF offered by BASF

Find a price of D-Panthenol bulk with CEP offered by BASF

Find a price of Detalan bulk with DMF offered by BASF

Find a price of Ibuprofen bulk with DMF offered by BASF

Find a price of Ibuprofen Sodium bulk with DMF offered by BASF

Find a price of Menthol bulk with JDMF offered by BASF

Find a price of Octocrylene bulk with DMF offered by BASF

Find a price of Omega-3-Acid Ethyl Esters 90 bulk with DMF offered by BASF

Find a price of Pantothenic Acid bulk with CEP offered by BASF

Find a price of Polyethylene Glycol Monostearate bulk with DMF offered by BASF

Find a price of Triclosan bulk with DMF offered by BASF

Find a price of Vitamin D3 bulk with DMF offered by BASF

Find a price of 5-Ethenyl-Pyrrolidin-2-One bulk offered by BASF

Find a price of Benzoic Acid bulk offered by BASF

Find a price of Beta Carotene bulk offered by BASF

Find a price of Calcium Ascorbate bulk offered by BASF

Find a price of DHA bulk offered by BASF

Find a price of Diethylhexyl Phthalate bulk offered by BASF

Find a price of Doxazosin Mesylate bulk offered by BASF

Find a price of Fluoxetine Hydrochloride bulk offered by BASF

Find a price of Hexanedioic Acid, Polymer With 1,6-Hexanediol bulk offered by BASF

Find a price of Isotretinoin bulk offered by BASF

Find a price of Macrogol bulk offered by BASF

Find a price of Paracetamol bulk offered by BASF

Find a price of Pyridoxine Hydrochloride bulk offered by BASF

Find a price of Riboflavin bulk offered by BASF

Find a price of Sibutramine Hydrochloride bulk offered by BASF

Find a price of Sodium Ascorbate bulk offered by BASF

Find a price of Tazarotene bulk offered by BASF

Find a price of Terazosin HCl bulk offered by BASF

Find a price of Thiamine Hydrochloride bulk offered by BASF

Find a price of Thiamine Mononitrate bulk offered by BASF

Find a price of Tretinoin bulk offered by BASF

Find a price of Vitamin A Acetate bulk offered by BASF

Find a price of Vitamin A Palmitate bulk offered by BASF

Find a price of Vitamin D3 bulk offered by BASF

Find a price of Vitamin E bulk offered by BASF

Find a price of STERILE AREA 1 DEPARTMENT AT MONZA FACILITY IN MILAN, ITALY. bulk offered by BASF

Find a price of KOLLIDON 12 PF, POLYVINYLPYRROLIDONE bulk offered by BASF

Find a price of UVINUL N539 SG bulk offered by BASF

Find a price of RADIO-PHARMACEUTICAL SYNTHESIS MODULE << SYNTHERArV1 >> bulk offered by BASF

Find a price of GLUCOPONA(R) 600 UP bulk offered by BASF

Find a price of N-[1-(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL 2-NAPHTHALENYL) bulk offered by BASF

Find a price of LUROTIN TM CAPSULES bulk offered by BASF

Find a price of MFG SITE FACILITIES OPERATING PROCEDURES AND PERSONEL FOR OSLO NORWAY bulk offered by BASF

Find a price of Bronopol bulk offered by BASF

Find a price of Calcium Pantothenate bulk offered by BASF

Find a price of Ibuprofen bulk offered by BASF

Find a price of Ibuprofen Lysinate bulk offered by BASF

Find a price of Levomenthol bulk offered by BASF

Find a price of Zinc Oxide bulk offered by BASF

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty